Overview

Catgut Embedding in Acupoints on Treating Persistent Atrial Fibrillation After Catheter Ablation

Status:
Not yet recruiting
Trial end date:
2023-12-20
Target enrollment:
Participant gender:
Summary
This is a multi-center, 2-arm, assessor and statistician blinded, pilot randomized controlled trial, to evaluate the effect of catgut embedding in acupoints of Neiguan and Zusanli in reducing early recurrence and improving long-term prognosis in patients with persistent AF after CA..
Phase:
N/A
Details
Lead Sponsor:
Shanghai Chest Hospital
Treatments:
Amiodarone